JPMorgan Chase Stock Today (Nov. 29, 2025): Insider Selling, Institutional Buying and a Bold London HQ Bet

JPMorgan Chase Stock Today (Nov. 29, 2025): Insider Selling, Institutional Buying and a Bold London HQ Bet

JPMorgan Chase & Co. (NYSE: JPM) heads into the final month of 2025 with its stock hovering near record highs, even as fresh headlines highlight insider selling, intense institutional repositioning, a major London headquarters project and a louder call from the bank’s own economists for earlier Federal Reserve rate cuts.

For investors watching JPM stock on Nov. 29, 2025, the story is less about a single catalyst and more about how all these moving parts fit together: strong earnings, premium valuation, shifting rate expectations and long‑term strategic bets.


Where JPMorgan stock stands going into December

Because Nov. 29 falls on a Saturday, the latest trading snapshot comes from Friday’s close:

  • Last close: JPMorgan shares finished around $313.08, up about 1.77% on the day and ahead of the S&P 500’s 0.54% gain. [1]
  • Intraday levels: The stock opened near $313.26, roughly where MarketBeat’s “today” snapshot also pegs the name. [2]
  • 52‑week range: About $202.16 at the low end and $322.25 at the high, leaving JPM trading close to the upper band of its yearly range. [3]
  • Market cap & valuation: JPMorgan’s market value is roughly $850+ billion, with a trailing P/E near 15.5, a PEG ratio around 1.8, and a dividend yield just under 2% after its latest payout hike. [4]

A MarketBeat deep dive notes that JPM stock is up just over 30% in 2025, far outpacing the broader U.S. banking sector, even though day‑to‑day moves have been unusually steady rather than explosive. [5]

In other words, JPMorgan isn’t acting like a meme stock—it’s acting like a heavyweight blue‑chip that has already enjoyed a big run. That context is crucial for interpreting today’s news.


Nov. 29, 2025 news: A flood of institutional filings

The single biggest volume of news on Nov. 29 comes from institutional ownership updates based on recent 13F and related SEC filings, compiled across the day by MarketBeat. [6]

On Nov. 29 alone, the feed shows a string of fund‑specific headlines, including (among many others): [7]

  • Willis Investment Counsel reporting nearly $20 million in JPM holdings
  • Large European players like ABN AMRO Bank N.V. disclosing new positions
  • Multiple wealth managers—Neo Ivy Capital Management, Dynamic Technology Lab, Archvest Wealth Advisors, Marvin & Palmer and others—initiating or adding to positions
  • Some big names trimming exposure, including Legal & General Group Plc, DNB Asset Management AS, Bank Julius Baer & Co. Ltd Zurich and Lodestone Wealth Management, which reported selling tens of thousands of shares

One standout:

  • Hillsdale Investment Management lifted its JPM stake by about 368% in Q2, ending the period with 30,652 shares worth roughly $8.9 million after buying an additional 24,110 shares. [8]

Another eye‑catching data point:

  • JPMorgan itself increased its position in its own stock by 5.1% in Q2, buying an extra 232,961 shares to hold roughly 4.8 million JPM shares valued around $1.39 billion as of the filing. [9]

Across these filings, MarketBeat estimates that about 71.5% of JPMorgan stock is owned by hedge funds and other institutional investors. [10]

What this means for investors:

  • The Nov. 29 tape doesn’t show a one‑way bet. Some managers are adding aggressively, others are locking in profits.
  • The sheer number of filings reinforces JPM’s status as a core institutional holding—this is one of the most widely held financial stocks in the world.
  • JPMorgan’s own purchase of its shares sits on top of a $50 billion buyback authorization, with more than $41 billion still available as of late Q3, according to Zacks’ analysis. [11]

Put together, Nov. 29’s filings read as active repositioning around a crowded favorite, not a mass exit or speculative stampede.


Insider selling: Caution signal or normal profit‑taking?

While institutions shuffle their exposure, insider activity has raised eyebrows. A Simply Wall St analysis syndicated via Yahoo Finance highlighted that JPMorgan insiders have sold about US$334 million worth of shares over the past year, framing it as a possible note of caution around the current valuation. [12]

MarketBeat’s holdings coverage adds more color: [13]

  • Director Linda Bammann sold 9,500 shares in early September at roughly $298, trimming her position by just over 10% but still retaining more than 80,000 shares.
  • Insider Robin Leopold sold 966 shares in early November at around $312, a reduction of roughly 1.6% of her stake.
  • Corporate insiders collectively own about 0.47% of JPMorgan’s outstanding shares.

How to read this:

  • At mega‑caps like JPMorgan, insider selling is common and often driven by personal diversification or tax planning rather than a bearish view.
  • The size of insider ownership is very small compared with institutional holdings, so trades tend to have more sentiment impact than direct effect on the float.
  • Viewed alongside the buyback and big institutional inflows, the insider selling looks more like profit‑taking into strength than a coordinated vote of no confidence.

Still, when you combine premium valuation (more on that below) with large dollar amounts of insider selling, it understandably makes new buyers more sensitive to entry price.


Q3 2025: JPMorgan is executing almost flawlessly

All of this sits on top of a strong fundamental story. JPMorgan’s Q3 2025 earnings, released Oct. 14, were impressive even by its own high standards:

  • Revenue: Around $47.1–47.12 billion, up roughly 9–10% year‑on‑year, beating consensus estimates by about 4%. [14]
  • Net income: About $14.4 billion, with a return on tangible common equity (ROTCE) of ~20%, according to the firm’s earnings release and SEC filing. [15]
  • Earnings per share:$5.07, roughly 16% higher than the prior year and well ahead of analyst expectations around $4.83. [16]
  • Revenue mix:
    • Net interest income rose about 2% to roughly $24.1 billion, even as rates have started to drift lower. [17]
    • Investment banking fees climbed around 16%.
    • Fixed income and equity trading revenues jumped by about 21% and 33%, respectively, driving record Q3 Markets revenue near $9 billion. [18]
    • Asset & Wealth Management posted record revenue of about $6.1 billion, up roughly 12%. [19]

Margins and returns look equally solid:

  • Net margin around 21% and return on equity near 17% underline that JPM remains one of the most profitable large banks globally. [20]

The bank also continues to reward shareholders:

  • The quarterly dividend was raised to $1.50 per share (about $6.00 annually), implying a yield around 1.9% at current prices and a payout ratio just under 30%. [21]

The short version: fundamentals are not the problem. If investors are hesitating, it’s largely about price and macro, not execution.


Valuation: Strong business, premium price

Fresh analysis from multiple research shops on Nov. 28–29 zeroes in on valuation:

Zacks: “Exceeds market returns” but only a Hold

A new Zacks note (distributed via Sharewise) points out that: [22]

  • JPM’s latest close at $313.08 beats the broader market on the day.
  • Over the past month, the stock is slightly down (~0.6%), lagging the broader Finance sector but still outperforming the S&P 500’s modest decline.
  • Street consensus now looks for Q4 EPS around $4.90 and full‑year 2025 EPS of about $20.24, with revenue near $182.45 billion, implying low‑single‑digit growth versus last year.

On valuation, Zacks estimates a forward P/E of ~15.2 and a PEG ratio of ~1.57, noting that JPM trades at a discount to the average forward P/E of the broader Finance sector but a higher PEG than its immediate investment‑banking peer group. [23]

The stock carries a Zacks Rank of #3 (Hold), which effectively says: high quality name, respectable upside, but not screamingly cheap at current levels.

Zacks premium‑valuation deep dive

A separate Zacks piece, carried by Finviz, goes further, arguing that JPM stock is “trading at a premium to peers” but may deserve much of that premium. Key points: [24]

  • JPM’s price‑to‑tangible book (P/TB) is about 3.09x, higher than the industry average around 2.97x, and well above Bank of America at 1.93x and Citigroup at 1.11x.
  • Quarter‑to‑date, JPM shares are down about 2.5%, underperforming BofA (+2.7%) and Citi (+0.9%), and trailing the broader market.
  • The article argues JPM deserves a valuation premium thanks to:
    • A diversified four‑segment model (consumer, commercial & investment banking, asset & wealth management, and corporate)
    • One of the industry’s largest, lowest‑cost deposit bases
    • A loans‑to‑deposit ratio near 56%, giving ample balance sheet flexibility
    • A growing share of fee‑based revenues (~45% of net revenues), which reduces sensitivity to interest rates

But it also warns that:

  • Net interest income will face pressure as the Fed shifts from hiking to cutting.
  • Credit costs and provisions remain elevated relative to pre‑pandemic norms.
  • Competition from fintechs and non‑bank financials continues to intensify.

The conclusion:

  • If you already own JPM, Zacks suggests holding the position.
  • New investors, however, might want to wait for a better entry point rather than chase the stock after a 30% year‑to‑date run.

Other valuation voices

Recent Seeking Alpha pieces strike a similar tone, describing JPMorgan as a high‑quality bank that’s “not a great buy at this valuation” and encouraging investors to wait for a correction before adding despite strong Q3 results. [25]

At the same time, MarketBeat’s Q3 review reiterates that JPM remains one of the best‑positioned banks in the U.S., but acknowledges that after such a big 2025 rally, the stock may be hitting near‑term valuation resistance even as analyst price targets inch higher. [26]


Macro backdrop: JPMorgan itself is calling for earlier Fed cuts

On Nov. 28, JPMorgan’s economics team made waves by pulling forward its call for the first Fed rate cut, now expecting a 25‑basis‑point move in December rather than January, followed by another cut early in 2026. [27]

Commentary from MarketMinute and FinTech Magazine highlights several key ideas: [28]

  • Recent remarks from Fed officials, including New York Fed President John Williams, have “tilted the odds” toward a December cut.
  • JPMorgan’s strategists still expect at least two cuts over the coming months, part of a broader easing cycle.
  • The bank’s head of global market strategy, Dubravko Lakos‑Bujas, projects the S&P 500 could reach around 7,500 by the end of next year, and possibly exceed 8,000 in 2026, assuming continued AI‑driven earnings growth and further monetary easing.

For JPMorgan as a stock, earlier cuts are a mixed blessing:

  • Lower rates are good for credit quality, capital markets, and equity valuations overall.
  • But they tend to compress net interest margins, a key earnings driver for banks.

That tension is baked into much of today’s commentary: JPM looks incredibly strong, but expectations for the cycle—and the Fed—are becoming just as important as the bank’s own execution.


Strategic expansion: A mega‑tower in London’s Canary Wharf

Another major storyline that continues to underpin sentiment around JPM stock is the bank’s new UK headquarters plan, announced this week and widely covered by Reuters and others. [29]

Highlights:

  • JPMorgan will build a 3‑million‑square‑foot tower at the Riverside South site in London’s Canary Wharf, more than twice the floorspace of The Shard and even larger than its newly completed New York HQ. [30]
  • The project is expected to:
    • Contribute about £9.9 billion (≈$13.1 billion) to the local economy over six years
    • Create around 7,800 jobs, including construction and local‑services roles
    • Ultimately house up to 12,000 JPMorgan employees [31]
  • The tower will be designed by Foster + Partners, also responsible for JPMorgan’s Park Avenue headquarters in New York. [32]

CEO Jamie Dimon has framed the decision as a “multi‑billion‑pound vote of confidence” in the UK economy and London’s status as a financial center, while UK Chancellor Rachel Reeves called it a landmark moment for Canary Wharf. [33]

For shareholders, the key takeaway is strategic, not near‑term financial:

  • The project doesn’t change next quarter’s EPS, but it underscores JPMorgan’s ambition to remain a scale leader in EMEA, support the expansion of its UK retail brand Chase, and anchor its post‑Brexit footprint in London.

Investors evaluating JPM today are effectively weighing this sort of multi‑decade growth bet against a valuation that is already pricing in a lot of good news.


So is JPM stock a buy right now?

From a news‑driven view on Nov. 29, 2025, the JPMorgan story looks something like this:

  • Fundamentals: Q3 results were excellent across almost every line of business; profitability and capital returns remain top‑tier for global banks. [34]
  • Shareholder returns: The dividend is growing, the payout ratio remains conservative, and the buyback capacity is enormous. [35]
  • Ownership flows: Institutions are actively repositioning but remain heavily invested; JPMorgan itself is a net buyer of its stock, even as some insiders sell into strength. [36]
  • Valuation: The stock trades at a premium to bank peers on book value and growth metrics, and multiple independent analyses now label it a “Hold” or “wait for a pullback” rather than a bargain. [37]
  • Macro: JPMorgan is forecasting earlier and deeper Fed cuts and a powerful AI‑driven earnings cycle, which is bullish for equities but could limit future upside for bank margins. [38]
  • Strategy: The London mega‑tower and aggressive branch and technology investments show a bank playing offense, not defense. [39]

For short‑term traders, today’s news leans slightly cautious: premium valuation, insider selling headlines, and a stock already up ~30% this year suggest the easy money has likely been made.

For long‑term investors, the Nov. 29 news flow mostly reinforces the existing thesis: JPMorgan remains one of the highest‑quality banks on the planet, executing well, returning capital consistently, and investing for the next decade—just don’t expect it to be cheap while it’s doing all of that.

As always, this article is informational only and not financial advice. Before buying or selling JPM or any other stock, consider your risk tolerance, time horizon, tax situation, and whether bank exposure fits your overall portfolio strategy.

Stocks Finish Powerful Week; Vertiv, Expand Energy, JPMorgan Chase In Focus | Stock Market Today

References

1. www.sharewise.com, 2. www.marketbeat.com, 3. www.marketbeat.com, 4. www.marketbeat.com, 5. www.marketbeat.com, 6. www.marketbeat.com, 7. www.marketbeat.com, 8. www.marketbeat.com, 9. www.marketbeat.com, 10. www.marketbeat.com, 11. finviz.com, 12. finance.yahoo.com, 13. www.marketbeat.com, 14. www.marketbeat.com, 15. www.jpmorganchase.com, 16. www.marketbeat.com, 17. www.marketbeat.com, 18. www.marketbeat.com, 19. www.marketbeat.com, 20. www.marketbeat.com, 21. www.marketbeat.com, 22. www.sharewise.com, 23. www.sharewise.com, 24. finviz.com, 25. seekingalpha.com, 26. www.marketbeat.com, 27. markets.chroniclejournal.com, 28. markets.chroniclejournal.com, 29. www.reuters.com, 30. www.reuters.com, 31. www.reuters.com, 32. www.reuters.com, 33. www.reuters.com, 34. www.marketbeat.com, 35. www.marketbeat.com, 36. www.marketbeat.com, 37. finviz.com, 38. fintechmagazine.com, 39. fintechmagazine.com

CoreWeave (CRWV) Stock on November 29, 2025: Insider Selling, Analyst Cuts and New Institutional Buying
Previous Story

CoreWeave (CRWV) Stock on November 29, 2025: Insider Selling, Analyst Cuts and New Institutional Buying

Johnson & Johnson (JNJ) Stock Near Record Highs: Today’s News, Earnings, Dividend and Talc Risks – November 29, 2025
Next Story

Johnson & Johnson (JNJ) Stock Near Record Highs: Today’s News, Earnings, Dividend and Talc Risks – November 29, 2025

Go toTop